Achillion Pharmaceuticals, Inc. Early in the week, we saw Achillion Pharmaceuticals, Inc.
Biotechnology company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its …
Cowen analyst Phil Nadeau weighed in today with a few observations on Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), following the company’s announcement that it has partnered its …
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced today that it has entered into a worldwide license and collaboration arrangement with Janssen Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Gilead Sciences, Inc.
MannKind Corporation (NASDAQ:MNKD) shares increased approximately 4.5% in pre-market trading to $4.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Achillion Pharmaceuticals stock is soaring in the market today.
